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DLGH1 Is a Negative Regulator of T-Lymphocyte Proliferation䌤†
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Ramnik Xavier,2* and Wojciech Swat1*
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Discs large homolog 1 (DLGH1), a founding member of the membrane-associated guanylate kinase family
of proteins containing PostSynaptic Density-95/Discs large/Zona Occludens-1 domains, is an ortholog of the
Drosophila tumor suppressor gene Discs large. In the mammalian embryo, DLGH1 is essential for normal
urogenital morphogenesis and the development of skeletal and epithelial structures. Recent reports also
indicate that DLGH1 may be a critical mediator of signals triggered by the antigen receptor complex in T
lymphocytes by functioning as a scaffold coordinating the activities of T-cell receptor (TCR) signaling proteins
at the immune synapse. However, it remains unclear if DLGH1 functions to enhance or attenuate signals
emanating from the TCR. Here, we used Dlgh1 gene-targeted mice to determine the requirement for DLGH1
in T-cell development and activation. Strikingly, while all major subsets of T cells appear to undergo normal
thymic development in the absence of DLGH1, peripheral lymph node Dlgh1ⴚ/ⴚ T cells show a hyperproliferative response to TCR-induced stimulation. These data indicate that, consistent with the known
function of Discs large proteins as tumor suppressors and attenuators of cell division, in T lymphocytes,
DLGH1 functions as a negative regulator of TCR-induced proliferative responses.
tentially allowing integration of structural functions with gene
expression patterns, as has been shown for CASK (14).
While the majority of the literature concerning PDZ proteins has focused on their functions in neuronal and epithelial
cells (3–5, 7, 15), recent studies have implied broader roles for
these proteins in polarity determination in nonclassical synaptic systems, including in the immune synapse (10, 11, 32). For
example, a founding member of the MAGUK family, Discs
large homolog 1 (DLGH1), has recently been proposed to play
a crucial role in regulating TCR signaling and T-cell polarity,
along with the LAP family protein Scribble and the CARD
family protein CARMA1, as well as several PAR family proteins (2, 12, 16, 23–25, 32, 33). However, the physiological
relevance of these interactions is not completely understood.
For example, it is unclear if DLGH1 plays an activating or
inhibitory function in regulating TCR signaling (25, 32).
DLGH1 contains multiple protein interaction domains characteristic of proteins involved in signal transduction, including
three N-terminal PDZ domains, a Src homology 3 domain, an
i3 domain, a 4.1-binding domain, and a C-terminal guanylate
kinase domain that lacks catalytic activity. Previous reports
have shown that DLGH1 is expressed at high levels in developing and mature T cells and, following TCR activation, is
recruited to lipid rafts and translocated to the immune synapse, where it can couple the TCR with Lck, Zap70, Vav,
WASP, and p38 kinase and may influence signaling specificity
(16, 24, 25, 32). However, the exact role of DLGH1 in T cells
is unclear, as its downregulation by means of small interfering
RNA (siRNA) in T-cell lines has been shown to alternatively
attenuate and augment T-cell activation (24, 25, 32).
To gain further insights into the physiological role of
DLGH1 in TCR signaling, we generated Dlgh1-deficient mice
by gene targeting. Since mice harboring homozygous Dlgh1-

Engagement of the T-cell receptor (TCR) complex initiates
signal transduction pathways involving protein and lipid kinases, phosphatases, and adapter proteins. Signals emanating
from the TCR are thought to be modulated by the recruitment
of transmembrane and cytosolic adaptor proteins, including
PostSynaptic Density-95/Discs large/Zona Occludens 1 (PDZ)
domain-containing scaffolds of the membrane-associated
guanylate kinase (MAGUK) family. PDZ domains can bind to
proteins via several mechanisms, the most common of which is
through binding of conserved carboxyl-terminal sequences of
proteins (8, 19, 27). Several studies suggest that PDZ domain
proteins play critical functions in the compartmentalization
of protein complexes and the asymmetric distribution of proteins
into synaptic interfaces (3–5, 7, 15). In T cells, the evidence to
date indicates that MAGUK proteins may interact with several
proteins harboring PDZ ligands implicated in the regulation of
TCR signaling and the coordination of T-cell polarity networks
(16, 24, 25, 32). In addition to functioning as plasma membrane-proximal scaffolds, some PDZ proteins translocate to
the nucleus and participate in transcriptional complexes, po-
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MATERIALS AND METHODS
Mice. The generation of the null allele of Dlgh1 has been previously described
(17). Mice were maintained as Dlgh1 heterozygous in the specific-pathogen-free
facility of Washington University School of Medicine in accordance with institutional policies for animal care and usage. C57BL/6 Rag-2⫺/⫺ mice were sublethally irradiated (600 rads) and reconstituted with fetal liver cells from
Dlgh1⫹/⫹, Dlgh1⫹/⫺, or Dlgh1⫺/⫺ embryonic day 15.5 (E15.5) to E18 embryos.
Survival rates were similar in lethally irradiated mice reconstituted with Dlgh1sufficient and Dlgh1-deficient donor cells. The mice were analyzed 6 to 10 weeks
following reconstitution. In all assays, no differences were found between
Dlgh1⫹/⫹ and Dlgh1⫹/⫺ T lymphocytes, and mice reconstituted with Dlgh1⫹/⫹
and Dlgh1⫹/⫺ fetal liver cells were used interchangeably and designated wild type
(WT). The generation of mice with a conditionally deleted Dlgh1 allele is described in Fig. S2 and Materials and Methods in the supplemental material.
Flow cytometry. Single-cell suspensions were prepared from the spleens, thymus, and lymph nodes and stained with antibodies according to standard protocols. Antibody conjugates against the following markers were used: TCR␤,
Foxp3, CD2, CD4, CD5, CD8, immunoglobulin D, immunoglobulin M, CD21/
35, CD23, CD25, CD44, CD62L, and CD69 (BD Biosciences).
Stimulation and proliferation assays. Lymph node T cells were plated at 1 ⫻
106/ml in complete Dulbecco’s modified Eagle’s medium-10% fetal bovine serum
(FBS). The cells were stimulated with the indicated concentrations of soluble
anti-CD3 and, when indicated, anti-CD28 (BD Biosciences) was used at 1 g/ml.
Proliferation assays using [3H]thymidine were performed as previously described
(6). Labeling with 1 M carboxyfluorescein succinimidyl ester (CFSE Invitrogen)
was performed on lymph node T cells. Briefly, cells were incubated with CFSE
for 30 min at 37°C and then washed in complete medium. Labeled cells were
cultured with the indicated stimuli for 72 h. The cells were labeled with 1 M
bromodeoxyuridine (BrdU) (Sigma Aldrich) for 1 h at 37°C. After being surface
stained for CD4 and CD8, the cells were fixed with 4% paraformaldehyde,
washed with staining buffer, and then frozen at ⫺80°C in 10% FBS-90% dimethyl
sulfoxide for at least 1 h. After being thawed, the cells were refixed and then
permeabilized in 0.5% saponin-1% FBS/phosphate-buffered saline (PBS). The
permeabilized cells were treated with 30 g DNase I (Sigma Aldrich) for 1 h,
washed, and then stained with antibodies against BrdU (Invitrogen), followed by
7-amino-actinomycin D (BD Biosciences).
Ca2ⴙ fluxes. Cells were loaded with Fluo-4-AM (Invitrogen) (3 to 5 g/ml) for
30 min at 37°C with occasional vortexing. The cells were stained with antibodies
against CD4 or CD8, washed, resuspended in complete medium, and then
analyzed by flow cytometry. Unstimulated cells were run through the cytometer
for 20 seconds to establish a baseline and then stimulated with the indicated
concentration of anti-CD3, immediately followed by cross-linking with sheep
anti-hamster antibodies (Jackson ImmunoResearch Laboratories). Ca2⫹ fluxes
were measured for an additional 5 min, followed by the addition of ionomycin
(0.5 g/ml) for an additional 1 min.
Cytokine assays. Purified lymph node T lymphocytes (105) were incubated
with irradiated splenic cells from C57BL/6 Rag-2⫺/⫺ mice and anti-CD3 antibodies for 24 h. Supernatant cytokine concentrations were analyzed using Cytometric Bead Array Assays (BD Biosciences) according to the manufacturer’s
instructions.
Immunoblotting and immunochemistry. Purified T cells were stimulated with
anti-CD3, followed by cross-linking with anti-hamster antibodies. The cells were
washed with cold PBS and then lysed in cold NP-40 lysis buffer (0.5% NP-40, 50

mM Tris-Cl, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride,
supplemented with Complete protease inhibitors [Roche] according to the manufacturer’s specifications) for 10 min at 4°C. The lysates were cleared by centrifugation at 14,000 ⫻ g for 10 min at 4°C. Samples were analyzed by Western
blotting according to standard procedures using antibodies against phosphotyrosine (4G10; Upstate Biotechnology), phospho-Akt, phospho-p38, phosphoErk1/2 (Cell Signaling Technology), and Erk2 (Santa Cruz). For T-cell-conjugate
assays, white sulfate latex beads (Interfacial Dynamics) coated with anti-CD3
and anti-CD28 antibodies (10 g/ml) were incubated with purified T cells at a
ratio of 1 bead/cell for 30 min at 37°C. The conjugates were fixed with 4%
paraformaldehyde for 10 min and then plated onto poly-L-lysine-coated coverslips. The cells were stained with fluorescently labeled phalloidin and the indicated fluorescent conjugated antibodies and analyzed by confocal microscopy.
Semiquantitative and real-time PCRs. CD8⫹ T cells were purified from lymph
node suspensions using magnetic sorting with anti-CD8 beads (Miltenyi Biotech;
(purity, ⬎90%). The cells were stimulated on plates coated with anti-CD3 (1
g/ml) plus soluble anti-CD28 (1 g/ml) for 18 h and harvested in Trizol (Invitrogen), and RNA was extracted according to the manufacturer’s instructions.
The extracted RNA was treated with 10 U RNase-free DNase for 15 min at 37°C.
cDNA was generated using avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) according to the manufacturer’s instructions. Semiquantitative PCR was performed on fourfold dilutions of the cDNAs. Real-time PCR
was performed using an MX300P cycler (Stratagene).

RESULTS
DLGH1 is a negative regulator of T-cell proliferation. TCR
ligation initiates multiple signaling cascades, culminating in the
induction of cell division and proliferation. In this context,
DLGH1 has been hypothesized to act as a scaffolding protein
in T lymphocytes, the function of which is to integrate and
coordinate multiple signaling cascades. To conclusively address the requirement for DLGH1 in the induction of proliferative responses in primary (naı̈ve) T cells, we utilized mice
harboring a gene-targeted Dlgh1-null allele (17). Since mice
homozygous for the null allele of Dlgh1 exhibit perinatal lethality (17), we used Rag-2-deficient complementation to generate Dlgh1-deficient T cells. To this end, irradiated Rag-2deficient mice were reconstituted with E15.5 to E18 fetal liver
cells from Dlgh1⫺/⫺, Dlgh1⫹/⫺, or Dlgh1⫹/⫹ embryos. Of note,
since no differences were observed in our analyses of Dlgh1⫹/⫺
versus Dlgh1⫹/⫹ cells (data not shown), we did not further
distinguish between these genotypes in any subsequent designations. Accordingly, Dlgh1⫹/⫺ and Dlgh1⫹/⫹ cells were designated WT and Dlgh1⫺/⫺ cells were designated knockout
(KO). Strikingly, our analyses of TCR-induced proliferative
responses of KO and WT T lymphocytes using [3H]thymidine
incorporation showed increased proliferation of KO T cells
(Fig. 1A and B). Thus, compared with WT T lymphocytes,
[3H]thymidine incorporation was enhanced in both CD8⫹ and
CD4⫹ KO T cells, although the effects were more pronounced
with CD8⫹ cells. This enhanced response was seen at all doses
of anti-CD3 antibodies tested but was most pronounced when
lower concentrations of stimulatory antibodies were used (Fig.
1A and B). Moreover, CFSE dye dilution assays demonstrated
that KO T lymphocytes underwent several more divisions in
response to stimulation with anti-CD3 or anti-CD3 and antiCD28 antibodies than WT cells. Again, this effect was most
pronounced at lower concentrations of activating stimuli (Fig.
1C and D). Of note, despite a clear reduction of the DLGH1
protein expression level in hemizygous cells (by approximately
twofold) (17), the proliferative responses of Dlgh1⫹/⫺ and
Dlgh1⫹/⫹ T cells were identical (data not shown), indicating
that downregulating DLGH1 to about half of its normal level
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null mutations show several developmental abnormalities and
die perinatally (17), we used recombination-activating gene 2
(Rag-2)-deficient complementation to generate Dlgh1-deficient
T cells. Here, we present biochemical and functional analyses
of Dlgh1-deficient T cells which indicate that DLGH1 is dispensable for TCR signaling and for normal thymic development. However, DLGH1 is critical for regulation of T-cell
proliferative responses. These results represent the first direct
demonstration of a role for a MAGUK protein in lymphocytes
using gene-targeted mice and indicate that DLGH1 functions
in the negative regulation of T-lymphocyte proliferation, consistent with the role of the fly ortholog of the mammalian
DLGH1, Discs large (DLG), which functions as an essential
tumor suppressor and an attenuator of cell proliferation in
imaginal discs during pupal development.
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did not affect T-cell proliferation. Taking these data together,
we conclude from these experiments that in resting (naı̈ve) T
cells, the loss of DLGH1 leads to an exaggerated TCR-induced
proliferative response.
Development of Dlgh1-deficient T lymphocytes. Exaggerated
TCR-induced proliferative responses of KO T lymphocytes
could potentially result from an abnormal developmental process, such as those observed in mice lacking negative regulatory
proteins, like Cbl, Csk, or SHP-1/2 (1, 18, 26, 28), all of which
show hyperresponsiveness to TCR stimuli. To determine if
DLGH1 is required for normal T-cell development, we analyzed thymic and peripheral T-cell subsets that developed in
Rag-2-deficient mice reconstituted with KO and WT fetal liver
cells. We found that both the total numbers and percentages of
thymocytes in double-negative (DN), double-positive, and single-positive CD4⫹ and CD8⫹ subsets were indistinguishable
between mice reconstituted with KO and WT cells (Fig. 2 and
Table 1). Also, the expression levels of TCR and several other
surface markers, including CD24, CD5, and CD2, were similar
in the two types of cells in all thymic subsets analyzed (Fig. 2).
In addition, our analyses of DN subsets of thymocytes, which
can be subdivided based on the expression of CD44 and CD25
into four populations, CD44⫹ CD25⫺ (DN1), CD44⫹ CD25⫹
(DN2), CD44⫺ CD25⫹ (DN3), and CD44⫺ CD25⫺ (DN4),
showed no significant differences between KO and WT chimeras (data not shown). We also analyzed the populations of
peripheral T lymphocytes in spleens and lymph nodes of mice
reconstituted with WT and KO fetal liver cells, which showed
normal numbers and percentages of mature CD4⫹ and CD8⫹
subsets (Fig. 2 and Table 1). Moreover, WT and KO peripheral
T cells expressed similar levels of TCR and other surface
markers, including CD62L, CD44, CD5, CD25, and CD69
(Fig. 2), and showed similar populations of T-regulatory cells,

as indicated by staining for intracellular Foxp3 (Fig. 2). Taking
these data together, we conclude from these experiments that
DLGH1 is not required for normal thymocyte or peripheralT-lymphocyte development in adult mice.
During thymic development, DLGH1 could be involved in
the regulation of either thymocyte-intrinsic or thymocyte-extrinsic (or thymic stroma cell-intrinsic) signals, or both. For
example, genes involved in Wnt signaling pathways, which have
previously been implicated in DLGH1 function (13), can exert
their developmental cues via thymic epithelial cell-intrinsic
mechanisms (21, 29). Given that in Rag2-complemented Dlgh1
chimeras thymic stroma is derived from the Rag2-deficient host
tissue (which is Dlgh1 sufficient), we analyzed the development
of thymocytes in germ line Dlgh1-deficient embryos, in which
both stroma and thymocyte progenitors lack DLGH1. Our
analyses of Dlgh1-deficient fetal thymic development, starting
immediately after thymic colonization with hematopoietic progenitors at E14 throughout the late stages of fetal development
at E18, showed no substantial differences between KO and WT
embryos (see Fig. S2 in the supplemental material). Thus,
development of embryonic DN1 to -4, immature CD8⫹ singlepositive, and double-positive subsets is similar in Dlgh1-deficient and Dlgh1-sufficient embryos. We conclude from these
experiments that DLGH1 is dispensable for normal thymic
differentiation during fetal development.
As an alternative approach, we also generated and analyzed
mice harboring a conditional (“floxed”) Dlgh1 allele, in which
DLGH1 expression can be ablated in T-lineage cells in the
presence of lck-Cre transgenes (see Fig. S2 in the supplemental
material). Consistent with the results of analyses of Rag-2/
Dlgh1 chimeric mice, mice with conditionally deleted Dlgh1
showed normal development of thymocytes and peripheral T
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FIG. 1. Proliferation of Dlgh1⫺/⫺ T lymphocytes. (A and B) Purifed CD8⫹ and CD4⫹ T cells from Rag-2-null mice reconstituted with WT or
KO fetal liver cells were stimulated with the indicated concentrations of stimulatory anti-CD3 (g/ml) with or without the addition of anti-CD28
(1 g/ml) and analyzed for [3H]thymidine incorporation. Shown are raw cpm values from one experiment, representative of three, all with similar
results. The error bars indicate standard deviations. (C and D) Lymph node cells from mice reconstituted with WT or KO fetal liver cells were
loaded with CFSE and stimulated with the indicated concentrations of anti-CD3 or anti-CD3 plus anti-CD28 (1 g/ml). The cells were analyzed
72 h poststimulation. Shown is one representative sample from the indicated CD4⫹ or CD8⫹ gate (n ⬎ 5), all with similar results. Shown in bar
graphs below the histograms is one representative experiment (in which the lymphocytes were stimulated with 0.1 g/ml anti-CD3) showing the
percentage of cells in each generation peak as calculated from the cell counts per peak.
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lymphocytes (data not shown; see Fig. S2E and F in the supplemental material).
We also addressed the possibility that DLGH1 may be required for T-cell responses to chemokine gradients, such as
stromal cell-derived factor 1␣ (SDF-1␣), which have been
implicated in the regulation of normal thymic egress (30). In

TABLE 1. Lymphocyte populations in Rag-2-null mice
reconstituted with Dlgh1⫹/⫺ or Dlgh1⫺/⫺ fetal liver cellsa
No. of cellsb
T cells
Dlgh1

Thymus
Total
CD4⫹
CD4⫹
CD4⫺
CD4⫺

⫹/⫺

Dlgh1⫺/⫺

CD8⫹
CD8⫺
CD8⫹
CD8⫺

140.5 ⫾ 37.1
107.9 ⫾ 31.8
15.8 ⫾ 4.7
5.7 ⫾ 2.5
8.1 ⫾ 2.9

168.0 ⫾ 44.2
127.7 ⫾ 38.9
17.6 ⫾ 6.0
6.5 ⫾ 2.9
9.5 ⫾ 4.2

Spleen
Total
Total T cells
CD4⫹
CD8⫹

77.9 ⫾ 38.3
13.9 ⫾ 8.2
11.3 ⫾ 6.9
2.6 ⫾ 1.3

88.2 ⫾ 25.0
13.9 ⫾ 5.0
11.1 ⫾ 4.2
2.8 ⫾ 1.0

Lymph node
Total
Total T cells
CD4⫹
CD8⫹

103.3 ⫾ 33.3
37.7 ⫾ 11.9
28.5 ⫾ 9.3
9.8 ⫾ 3.7

108.2 ⫾ 44.9
39.0 ⫾ 17.8
28.5 ⫾ 13.7
11.1 ⫾ 4.5

a
b

Data are means ⫾ standard deviations and represent multiples of 106 cells.
Dlgh1⫹/⫺ consisted of 12 mice, and Dlgh1⫺/⫺ consisted of 13 mice.

this context, previous studies implicated Scribble, a DLGH1related protein, in SDF-1␣-mediated migration of T cells (16).
To address this issue, we analyzed the migration of T lymphocytes from KO or WT chimeras in response to increasing
concentrations of SDF-1␣ using a transwell assay. We found
that SDF-1␣-induced migration was indistinguishable between
KO and WT T lymphocytes (see Fig. S3 in the supplemental
material). These data indicate that in primary T lymphocytes,
DLGH1 is not required for chemokine-induced migration.
Collectively, our results support the hypothesis that Dlgh1 deficiency results in a distortion of TCR signals that leads to an
exaggerated proliferative response of T cells in vitro in the
absence of major alterations in their development in either
primary or secondary lymphoid organs.
Polarization of the actin cytoskeleton and recruitment of
polarity and signaling proteins to the immune synapse in the
absence of DLGH1. Actin cytoskeletal remodeling is critically
important for sustained TCR signaling and activation. The i3
domain of DLGH1 has been shown to interact with proteins of
the ezrin-radixin-moesin family, which couple proteins to the
actin cytoskeleton. While DLGH1 is found in the immunological synapse following TCR cross-linking, a previous report
indicated that cells expressing decreased levels of DLGH1 due
to siRNA knockdown have diminished polymerized actin content and disrupted clustering and raft formation following
TCR stimulation (25). To determine if DLGH1 is required for
actin polymerization in primary Dlgh1-deficient T cells, we
analyzed cytoskeletal remodeling and polarization toward a
TCR-stimulatory target. Freshly isolated T lymphocytes from
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FIG. 2. Lymphocyte development in Rag-2-null mice reconstituted with KO fetal liver cells. Single-cell suspensions of thymocytes, splenocytes,
or lymph node cells were counted, stained with the indicated fluorescent-antibody conjugates, and analyzed by flow cytometry as described in
Materials and Methods. For analyses of CD44, CD62L, and Foxp3, the populations shown are from the indicated CD4 and CD8 gates. The data
shown are from a representative experiment (n ⬎ 5).
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KO and WT chimeric mice were incubated with anti-CD3 and
anti-CD28 antibody-coated latex beads and then analyzed for
actin polymerization (as measured by accumulation of F-actin
using phalloidin staining). F-actin accumulations were similar
in WT and KO lymphocytes incubated with stimulatory beads
(Fig. 3A to C). As expected, few bead-cell conjugates were
found in cells incubated with control beads (coated with PBS/
bovine serum albumin), nor did these conjugates show F-actin
accumulation at the site of conjugation (data not shown).
Following TCR ligation and immune synapse formation,
DLGH1 has been shown to colocalize with the polarity protein
Scribble (16) and to associate with the signaling proteins Vav1
and ZAP-70, all of which are relocalized to the immune synapse following TCR cross-linking (16, 25, 32). To determine if
the TCR-induced relocalization of these proteins is altered in
the absence of DLGH1, we analyzed Scribble, Vav1, and
ZAP-70 localization using conjugate assays. In both CD4⫹ and
CD8⫹ cells, Scribble is localized to the immune synapse in a
manner indistinguishable between KO and WT T cells (Fig.
3A). Moreover, Vav1 and ZAP-70 were found in the synapses
of both KO and WT CD4⫹ and CD8⫹ T cells following TCR
ligation (Fig. 3B and C). Similarly, assays analyzing the polarization of microtubule organizing centers toward the TCRstimulatory target also showed no perturbations in the absence
of DLGH1 (data not shown). Together, these data indicate
that DLGH1 is not required for cytoskeletal remodeling and
the relocalization of Scribble, Vav1, and ZAP-70 following
TCR ligation in freshly isolated lymph node T cells.
TCR-induced signaling in Dlgh1-deficient T lymphocytes.
DLGH1 contains multiple domains involved in signal transduction and associates with several proteins downstream of
TCR activation (10, 11, 16, 24, 25, 32). However, it is unclear
whether DLGH1 is required for the regulation of TCR-proximal signaling pathways in primary T cells. Given that DLGH1
is constitutively associated with the Shaker-related potassium
channel Kv1.3 in T lymphocytes, which are implicated in the
regulation of Ca2⫹ entry in T lymphocytes (10, 22), we first
analyzed Ca2⫹ mobilization in freshly isolated T cells from KO
and WT chimeric mice. Following TCR cross-linking with various doses of anti-TCR antibodies, both KO and WT CD4⫹
and CD8⫹ lymph node T cells showed Ca2⫹ fluxes with
indistinguishable kinetics and magnitudes (Fig. 4A and data

not shown). These data indicate that in T lymphocytes,
DLGH1 is not required for Ca2⫹ mobilization following
TCR cross-linking.
We next analyzed TCR-induced protein tyrosine phosphorylation patterns and activation of downstream signaling pathways in WT and KO T lymphocytes. Consistent with normal
Ca2⫹ mobilization, the patterns of total protein tyrosine phosphorylation were similar in WT and KO T lymphocytes (Fig.
4B), and there were no significant differences in either the
kinetics or the magnitudes of activation of Erk1/2, Akt, and
p38 kinases (Fig. 4B; see Fig. S4 in the supplemental material).
Moreover, the upregulations of CD25 and CD69, early markers of T-cell activation, were similar in TCR-stimulated WT
and KO lymphocytes (see Fig. S5 in the supplemental material). To determine if DLGH1 is required for activation of
nuclear factor of activated T cells (NFAT), we analyzed WT
and Dlgh1-deficient T lymphocytes for their abilities to trans-

FIG. 4. Proximal signaling in KO T lymphocytes. (A) Lymph node
cells from RAG chimeric mice were loaded with Fluo-4-AM and then
stained with antibodies against CD4 (left) or CD8 (right). Cell suspensions were analyzed by flow cytometry for 20 seconds to determine
the background and then for an additional 5 min after anti-CD3 (1
g/ml) stimulation. Ionomycin was added at 5 min to achieve maximal
Ca2⫹ signaling. In each plot, the first arrow indicates the addition of
anti-CD3 and the second arrow indicates the addition of ionomycin.
(B) Purified T cells from mice reconstituted with WT or KO donor
cells were stimulated with 1 g/ml anti-CD3 for the indicated times.
Proteins were detected by Western blotting. Shown is one experiment,
representative of three, all with similar results.
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FIG. 3. Actin accumulation and recruitment of polarity and signaling proteins to the immune synapse in KO lymphocytes. (A to C) Purifed T
cells from chimeric mice were incubated with anti-CD3-coated latex beads for 30 min. The cells were stained with phalloidin and antibodies against
Scribble, Vav1, and Zap-70, followed by analysis by confocal microscopy. Shown is one experiment, representative of three. In each experiment,
⬎60 conjugates were analyzed. DIC, differential interference contrast.
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locate NFAT into the nucleus, which is mediated in the context
of calcineurin-dependent dephosphorylation. In these experiments, we found that TCR stimulation led to a rapid translocation of NFAT to the nucleus in both WT and Dlgh1-deficient
T cells, indicating that DLGH1 is not required for NFAT
activation (data not shown; see Fig. S4 in the supplemental
material). Together, these data suggest that DLGH1 is not
essential for activation of major components of TCR-induced
proximal signaling cascades leading to transcriptional activation of cytokine gene expression, including interleukin 2 (IL-2).
Cytokine production by Dlgh1-deficient T lymphocytes. The
production of IL-2 is critically dependent on the TCR-induced
activation and nuclear translocation of NFAT. Considering
that IL-2 production is critical for the proliferation of naı̈ve T
lymphocytes and that NFAT activation has been linked to
DLGH1 signaling (24, 25, 32), we hypothesized that the hyperproliferation of KO lymphocytes could result from enhanced IL-2 production. However, we found that TCR-induced IL-2 production was indistinguishable between WT and
KO CD4⫹ and CD8⫹ T lymphocytes (Fig. 5; see Fig. S6 in the
supplemental material). Similarly, there were no significant
differences in gamma interferon (IFN-␥) production between
WT and KO T lymphocytes (Fig. 5; see Fig. S6 in the supplemental material). These data show that DLGH1 is not required for the induction of IL-2 or IFN-␥ in primary T cells
and suggest that the perturbations in proliferation observed in
KO T cells do not result from deregulated cytokine production.
Increased S-phase entry and enhanced induction of c-myc in
Dlgh1-deficient T lymphocytes. To further characterize the hyperproliferative response of Dlgh1-deficient T lymphocytes, we
assayed the kinetics of cell cycle entry using BrdU incorporation and DNA content analyses in naı̈ve resting T cells (which
are predominantly in the G0/G1 phase of the cell cycle) upon
TCR stimulation. Strikingly, these assays showed that compared to Dlgh1-sufficient T lymphocytes, an increased percentage of KO T lymphocytes entered S phase at 18 h poststimulation (Fig. 6). Consistent with the results from the
[3H]thymidine incorporation and CFSE dye dilution experiments, this increased S-phase entry was more pronounced in
KO CD8⫹ T cells and only modestly increased in KO CD4⫹ T
cells. Next, we analyzed the levels of transcripts of c-myc, a
critical transcriptional regulator induced at the onset of proliferative responses of T lymphocytes. In these assays, we fo-

FIG. 6. KO CD8⫹ T-cell entry into S phase following anti-CD3
stimulation. Lymph node T cells from mice reconstituted with WT or
KO fetal liver cells were stimulated with the indicated concentrations
of stimulatory anti-CD3 and anti-CD28 antibodies (1 g/ml). The cells
were stimulated for 18 h, pulsed with BrdU, and stained with antibodies against BrdU. Shown are the mean values plus standard deviations
from five experiments.

cused our attention on CD8⫹ T cells, which exhibit a more
profound increase in TCR-induced proliferation. Indeed, we
observed that compared to the WT, c-myc transcript levels in
unstimulated KO CD8⫹ T cells were modestly increased, but
that following TCR induction, KO CD8⫹ T cells showed significantly greater induction of c-myc transcripts (Fig. 7A and
B). These data indicate that Dlgh1-deficient T cells exhibit
increased basal and induced expression of c-myc. Together,
these results indicate that KO T cells show enhanced proliferation following TCR stimulation and that cell cycle entry is
accelerated in Dlgh1-deficient lymphocytes, implicating

FIG. 7. c-myc transcripts in KO CD8⫹ T cells. (A) Semiquantitative reverse transcription-PCR analysis of c-myc induction in purified
CD8⫹ T cells from WT- or KO-reconstituted mice stimulated for 16 h
with 1 g/ml anti-CD3 and anti-CD28. Fourfold serial dilutions of
cDNA from one representative experiment of three is shown. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels were used for
normalization of cDNAs. (B) Quantitative RT-PCR analysis of purified CD8⫹ T cells from WT- or KO-reconstituted mice stimulated for
16 h with 1 g/ml anti-CD3 and anti-CD28. The data shown are mean
values (n ⫽ 3) normalized to GAPDH.
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FIG. 5. IL-2 and IFN-␥ production from Dlgh1-deficient T lymphocytes. The supernatants from purified T cells stimulated with the indicated concentrations of anti-CD3 antibodies for 24 h were assayed
for IL-2 and IFN-␥ production. Shown are the mean concentrations
plus standard deviations from five experiments.
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repertoire “shifts,” which could conceivably compensate for
gain or loss of signaling potency by individual TCR heterodimer complexes expressed by developing T cells. To conclusively address this issue, development and selection of
Dlgh1-deficient thymocytes will need to be addressed in the
context of “fixed” TCR repertoires, for example, by the introduction of conditional/inducible Dlgh1-null alleles into developing T cells that also harbor ␣␤ TCR-transgenes in a positively selecting major histocompatibility complex background
in the absence of expression of any endogenous ␣ and ␤ TCR
chain genes. Our second major finding is that DLGH1 is not
essential for TCR-induced F-actin accumulation and the recruitment of polarity proteins to the immune synapse, activation of the T-cell cytokines IL-2 and IFN-␥, or directional
migration toward chemokine gradients. Thirdly, we show that
in primary (naı̈ve) T cells, DLGH1 functions as a negative
regulator of TCR-induced proliferative responses in vitro.
Thus, in the absence of any gross alterations in TCR proximal
signal transduction events detectable in T cells lacking DLGH1
protein, DLGH1 appears to be required for normal regulation
of TCR signaling outcome and proliferative responses. Alternatively, DLGH1 may function as an adaptor protein regulating signal intensity in other transduction pathways contributing
to T-cell proliferation, such as those downstream of cytokine
receptors like IL-2 or IL-4. Of note, in our experiments, even
substantial downregulation of DLGH1 expression, such as that
observed in T cells with a hemizygous Dlgh1-null mutation
(Dlgh1⫹/⫺) (which equaled or exceeded 50% of total DLGH1
expression), did not lead to any detectable changes in T-cell
responses to TCR stimulation. Thus, our experiments show no
evidence of DLGH1 haploinsufficiency in developing and mature T cells. We note however, that Dlgh1 gene-deficient T cells
may conceivably undergo an in vivo selection process and/or
acquire some changes in their TCR signaling apparatus that
may compensate for the gain or loss of TCR signaling potency
during the course of their development. Also, a compensatory
mechanism(s) must exist in vivo for the regulation of T-cell
proliferation, as Dlgh1-deficient chimeras do not develop lymphoadenopathy, do not show any lymphoproliferative disorder,
and can produce T-dependent humoral responses that appear
similar to normal ones (data not shown).
Our studies suggest that DLGH1 is required for proper
regulation of c-myc expression in primary T cells. Numerous
previous studies have identified c-myc as a master regulator of
a transcriptional program linking extracellular signals to cell
cycle progression and cell division in a variety of cell types,
including T cells (9, 31). These results are intriguing, as
DLGH1 could potentially regulate c-myc via a pathway involving GSK3␤ and ␤-catenin (5, 20). However, at present we do
not understand the exact mechanism that may underlie any
such potential roles for DLGH1 in these signaling pathways in
T cells, as our experiments to directly address the requirement
for DLGH1 in ␤-catenin signaling in T cells were inconclusive
(data not shown). Nevertheless, whatever the mechanism, enhanced c-myc may underlie the accelerated cell cycle entry and
hyperproliferation in Dlgh1⫺/⫺ T cells. Importantly, while loss
of DLGH1 leads to considerable effects on c-myc expression,
we note that the expression of other DLGH family members,
notably DLGH3, may contribute redundant functions in the
absence of DLGH1 in T cells. In this regard, although we did
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Although the majority of previous studies of PDZ domaincontaining MAGUK proteins in mammalian systems have focused on their functions in neuronal and epithelial cells, more
recent studies indicate that PDZ proteins are also involved in
the regulation of T-lymphocyte activation and the establishment of synaptic polarity in the context of the immune synapse
(10, 11, 16, 32). Additionally, several reports implicate
DLGH1, a founding member of the MAGUK family, in regulating TCR signaling output. For example, our recent studies
demonstrated that DLGH1 participates in the assembly of
TCR-induced signaling complexes (32). Consistent with these
findings, studies published by other groups indicated DLGH1
involvement in the recruitment of several key components of
the TCR-induced proximal signaling complex, including Lck,
ZAP-70, and WASP (15, 24, 25). However, important differences remain in the interpretation of experimental data in
support of DLGH1 function downstream of the TCR, as our
studies (32) and those of others (25) reached opposite conclusions regarding DLGH1 function either as a positive or a
negative regulatory factor in TCR-induced responses.
Thus, in contrast to our report in which we concluded that
overexpression of DLGH1 attenuates while downregulation of
DLGH1 by siRNA enhances TCR signaling (32), Round et al.
found that DLGH1 overexpression potentiates NFAT-dependent transcriptional activation while DLGH1 downregulation
abrogates TCR-induced F-actin polymerization, lipid raft clustering, and TCR/CD3 capping and leads to defective cytokine
production, including IL-2 and IFN-␥, due to a block in NFATdependent transcriptional activation (24, 25). The latter results
are surprising, particularly given our previously published findings, but also in the context of a well-documented propensity of
mammalian DLGH proteins, and their Drosophila ortholog,
DLG, to function as tumor suppressors and attenuators of cell
division, as revealed in various experimental systems to date
(reviewed in reference 15). These differences could result from
the different experimental models utilized by our group and in
previous studies. Our initial studies used siRNA in immortalized T-cell lines (32), while Round et al. used siRNA knockdown of DLGH1 in OT-1 T cells that had been activated and
expanded in culture (24, 25). Thus, it is conceivable that
DLGH1 functions differently in regard to protein polarity and
signaling in antigen-experienced T cells.
In this study, by utilizing Dlgh1-null lymphocytes, we were
able to directly analyze the consequences of DLGH1 deficiency in development and activation of primary T cells. Since
mice homozygous for the null allele of Dlgh1 exhibit perinatal
lethality (17), we utilized Rag-2-deficient complementation
with Dlgh1-null fetal liver progenitors and mice with a conditionally targeted Dlgh1 allele to generate T cells lacking
DLGH1. Our experiments with these Dlgh1-deficient T cells
conclusively establish three major findings. First, we show that
DLGH1 is not essential for the differentiation of major thymic
or peripheral subsets of ␣␤ lineage T lymphocytes during both
fetal and adult development. An important caveat to this conclusion is that we cannot rule out potential effects of TCR
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not observe any substantial differences in the expression levels
of other DLGH family members in the absence of DLGH1
(data not shown), it is also possible that the expression of other
MAGUK family proteins, such as Scribble and Lgl, may provide a basis for partial functional redundancy with DLGH1 in
the regulation of TCR-induced events. Genetic deletion of
other DLGH family members and members of the related
families of other MAGUK proteins, in conjunction with deletion of Dlgh1, will be required to define the limits of any such
potential functional redundancies.
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